glp 1 agonist news GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness NEWS: NIH scientists have unveiled
Description
Newer drugs such as tirzepatide (Mounjaro, Zepbound) target GLP1 and GIP (dual agonist)
doi: 10.1080/00325481.2015.993276 98 GongNXiaoQZhuBZhangCYWangYCFanHet al
Petersen N, Reimann F, Bartfeld S, Farin HF, Ringnalda FC, Vries RGJ, et al
Dabaja A et al
Market Intelligence: The GLP-1 Shift The Trend: 47% rise in hair loss inquiries Primary Cause: Telogen Effluvium (Shedding) Metabolic Risk: Muscle Sarcopenia Skin Profile: Accelerated Laxity The Fix: The Piazza "Triple Threat" Protocol Target: Scalp, Skin, and Muscle Clinical Insight: Rapid weight loss triggers a survival response
The regulation of peripheral metabolism by gut-derived hormones
